Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experiment

This study enumerated patients’ preference-based personal utility and willingness-to-pay for massively parallel sequencing (MPS) genetic testing of colorectal cancer (CRC) risk. Our setting was the New Exome Technology in (NEXT) Medicine Study, a randomized control trial of usual care genetic testin...

Descripción completa

Detalles Bibliográficos
Autores principales: Weymann, Deirdre, Veenstra, David L., Jarvik, Gail P., Regier, Dean A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117311/
https://www.ncbi.nlm.nih.gov/pubmed/29802320
http://dx.doi.org/10.1038/s41431-018-0161-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117311/
https://www.ncbi.nlm.nih.gov/pubmed/29802320
http://dx.doi.org/10.1038/s41431-018-0161-z

Ejemplares similares